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ABSTRACT
Objective: To test the procedures proposed for a
main trial of a safer sex intervention for young people
delivered by mobile phone text message (‘safetxt’).
Design and setting: Pilot randomised controlled
trial. Participants were recruited through sexual health
services in the UK. An independent online
randomisation system allocated participants to receive
the safetxt intervention or to receive the control text
messages (monthly messages about participation in
the study). Texting software delivered the messages in
accordance with a predetermined schedule.
Participants: Residents of England aged 16–24 who
had received either a positive chlamydia test result or
reported unsafe sex in the last year (defined as more
than 1 partner and at least 1 occasion of sex without a
condom).
Intervention: The safetxt intervention is designed to
reduce sexually transmitted infection in young people
by supporting them in using condoms, telling a
partner about an infection and testing before
unprotected sex with a new partner. Safetxt was
developed drawing on: behavioural science; face-to-
face interventions; the factors known to influence safer
sex behaviours and the views of young people.
Outcomes: The coprimary outcomes of the pilot
trial were the recruitment rate and completeness of
follow-up.
Results: We recruited 200 participants within our target
of 3 months and we achieved 81% (162/200) follow-up
response for the proposed primary outcome of the main
trial, cumulative incidence of chlamydia at 12 months.
Conclusions: Recruitment, randomisation, intervention
delivery and follow-up were successful and a
randomised controlled trial of the safetxt intervention
is feasible.
Trial registration number: ISRCTN02304709;
Results.
INTRODUCTION
Background of the problem
The prevalence of genital chlamydia infec-
tion (hereafter referred to as ‘chlamydia’) in
the UK is highest among people aged 16–24,
estimated to be 3.1% for women and 2.3%
for men.1 Long-term adverse health effects
of chlamydia infection may include ectopic
pregnancy and subfertility, especially in those
with repeated infections.1 2 Reinfection
among young women treated for chlamydia
is particularly high.3 Skills such as negotiat-
ing condom use, notifying a partner about
an infection and testing can reduce the risk
of infection. However, young people can lack
the conﬁdence and skills needed to adopt
safer sex behaviours.4
Mobile phones for intervention delivery
Phone ownership in the UK is high, with an
estimated 93% of adults owning a personal
phone and 90% of people aged 16–24
owning a smart phone.5 Among young
people in the UK, mobile phones have
become constant companions; 59% say that
their mobile phones would be the device
that they would miss the most if taken away
and almost half (48%) report checking their
phones within 5 min of waking.5 Mobile
phones therefore have the potential to
deliver widely accessible and inexpensive
health behaviour support. With sensitive
Strengths and limitations of this study
▪ This pilot trial demonstrated that the proposed
procedures for a main trial of the safetxt inter-
vention are feasible.
▪ Follow-up was high compared with a similar trial
collecting sexually transmitted infection out-
comes. Additional strategies to increase follow-
up are needed.
▪ The safetxt intervention was acceptable to
recipients.
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health topics such as sexual health, mobile phones can
offer convenience and privacy.
Existing research
Interventions delivered by mobile phone can be effect-
ive in improving a range of behaviours such as smoking
cessation, adherence to medication and contraceptive
uptake.6–14 There is some evidence that mobile phone
support can increase safer sex behaviours; however, high-
quality trials are needed to reliably establish effects.15
A trial evaluating an intervention consisting of eight
safer sex text messages, aimed at increasing knowledge
and perceived behavioural control, reinforcing safer sex
behaviours and changing attitudes, found that interven-
tion participants were more likely to report using
condoms with new partners in the previous 3 months
compared with controls who received text messages not
about safer sex (OR 2.2, 95% CI 1.1 to 4.2). However,
this trial found little evidence for an intervention effect
on always using condoms in the previous 6 months (OR
0.8, 95% CI 0.5 to 1.4).16 An intervention consisting of
14 ‘short and catchy’ text messages providing advice and
information about sexually transmitted infection (STI),
increased STI testing in women compared with control
participants who did not receive the messages (OR 2.51,
95% CI 1.11 to 5.69).17 A trial of an intervention aimed
at retesting following a positive chlamydia test result
found a fourfold increase in testing in participants that
received text message reminders versus controls that
received the standard advice from a clinician (RR 4.5,
95% CI 1.05 to 19.22).18 None of these trials had a low
risk of bias or targeted partner notiﬁcation. The inter-
ventions evaluated in these trials included up to three
behaviour change techniques (intervention components
aimed at inﬂuencing behaviour).19
Intervention development
We developed an intervention delivered by text message
to target condom use, partner notiﬁcation and STI
testing. We developed the intervention based on: beha-
vioural science;19 20 the content of effective face-to-face
safer sex interventions;21 the factors known to inﬂuence
safer sex behaviours;4 22 the views of 82 young people
collected in focus group discussions23 24 and a question-
naire completed by 100 people aged 16–24.23 24 In inter-
views with 16 participants, young people reported that
the intervention tone, frequency and content were
acceptable.25 Our pilot trial builds on this successful
intervention development work.23
METHODS
The objective of this pilot trial was to test the procedures
proposed for a main trial of the safetxt intervention. We
aimed to recruit and randomise 200 participants within
3 months and achieve 80% response at each follow-up
point. There were no changes to the methods after the
trial started.
Eligibility criteria
Residents of England aged 16–24 who had received
either a positive chlamydia test result or reported unsafe
sex in the last year (deﬁned as more than one partner
and at least one occasion of sex without a condom),
were literate in English and who owned a personal
mobile phone were eligible.
Recruitment
We recruited participants from seven sexual health ser-
vices located in inner city Manchester, South London,
Cambridgeshire, Norfolk, Maidstone and Hull.
Recruitment staff enrolled participants at the service or,
with their permission, gave the telephone numbers of
eligible people to the trial manager at LSHTM who con-
tacted them by phone for recruitment. We gave all
potential participants detailed verbal and written infor-
mation, the opportunity to ask questions and time to
consider their participation. For participants recruited
by telephone, the trial manager emailed or texted the
link to the web-based information sheet and participants
provided informed consent by completing the form on
the secure study website. We recorded the number of
participants that were assessed, were eligible and
declined.
Treatment groups
Our texting software automatically delivered the inter-
vention or control messages to the mobile phone
number that participants provided at enrolment. The
software delivered the messages in accordance with a
predetermined message schedule. All participants had
the option of choosing embargoed times when they
would not receive messages.
The safetxt intervention
The safetxt intervention includes 12 behaviour change
techniques and involves the functions education, enable-
ment and incentivisation.19 20 23 It consists of short, non-
judgmental text messages designed to reduce STI in
young people by supporting them in using condoms,
telling a partner about an infection and testing before
unprotected sex with a new partner. There are four
intervention message sets, tailored to gender and infec-
tion status at enrolment sent over 12 months: women-
positive (63 messages), men-positive (61 messages),
women-negative (51 messages) and men-negative (49
messages). Around half of the messages in each set are
delivered in the ﬁrst month: 59% (37/63) of the
women-positive, 59% (36/61) of the men-positive, 49%
(25/51) of the women-negative and 49% (24/49) of the
men-negative messages (see online supplementary
ﬁle 1). The messages are delivered to each participant
according to the set schedule, that is, each participant
starts at message #1 and receives the message set con-
secutively. Participants who had a positive STI test result
at the time of enrolment received additional messages
during the ﬁrst week after randomisation on obtaining
2 McCarthy OL, et al. BMJ Open 2016;6:e013045. doi:10.1136/bmjopen-2016-013045
Open Access
and taking treatment and notifying partners about their
infection. See Free 2016 for a full details of the develop-
ment of safetxt.23
Control
Participants allocated to the control group received 13
messages, starting at the time of randomisation, spaced
30 days apart. The control messages reminded them of
their participation with the aim of keeping them
engaged in the trial. The control messages contained no
behaviour change techniques.
See online supplementary ﬁle 1 for the intervention
and control message frequency and online supplementary
ﬁle 2 for example intervention and control messages.
Outcomes
Primary outcomes
The coprimary outcomes were the recruitment rate and
the completeness of follow-up for assessment of the pro-
posed primary outcome for the main trial, cumulative
incidence of chlamydia at 12 months.
Process outcome data
We collected process outcome data at 1 and 12 months
postrandomisation.
Acceptability of the intervention
The 1-month questionnaire also collected data on parti-
cipants’ views of the messages. We gathered participant
views at 1 month because around half of the messages
were delivered within this period and we wanted to
maximise recall. An additional measure of acceptability
is the number of participants allocated to the interven-
tion that requested for the messages to stop.
Sample size
The pilot trial was designed to estimate the likely
follow-up rate at 12 months. If loss to follow-up in the
main trial was 20%, a pilot trial of 200 participants
would estimate the loss to follow-up with a precision of
6% (ie, a 95% CI of 14% to 26%).
Protection against bias
Randomisation
An independent online randomisation system (sealed
envelope) generated the 1:1 allocation sequence, assur-
ing allocation concealment. The sequence was stratiﬁed
by site using random permuted block sizes of 2, 4 and
6. No one involved in the research was aware of the
block sizes. The system randomised participants immedi-
ately after the baseline data were entered.
Blinding
As this is a behavioural intervention, participants were
aware of their treatment allocation and therefore were
non-blinded. The trial manager required access to
treatment allocation in order to identify intervention
participants for qualitative interviews.25 Laboratory staff
assessing chlamydia infection and researchers assessing
the outcomes were blinded to treatment allocation.
Research staff performing the statistical analysis were
blinded to treatment allocation. Data were double
entered, with one researcher blinded to allocation. The
treatment allocation variable in the data set was coded
1 or 2 and this was kept undisclosed to two of the three
research staff performing the analysis (one was the trial
manager) until the full analysis was complete.
Data collection and follow-up procedures
We assessed numbers recruited by the number rando-
mised during the 3-month time-period. We assessed
follow-up response by numbers completing the question-
naire at 1 and 12 months and numbers returning a chla-
mydia test sample at 3 and 12 months. We also collected
clinic data for tests within the 12-month follow-up period.
We recruited participants face-to-face in clinics and by
telephone, depending on the service. We collected
baseline data by paper questionnaire in face-to-face
recruitment. At the Cambridge service, staff assessed
eligibility when providing positive chlamydia test results
over the phone. With the potential participant’s agree-
ment, staff at the service provided their telephone
number to the Project coordinator, who then contacted
the participant to enrol them and collect baseline data
over the phone. Recruitment staff who obtained
informed consent and administered the baseline ques-
tionnaire entered the baseline data onto a secure
online trial database system. If the test result was
pending when the participant was enrolled, recruitment
staff entered the baseline data onto the system within
24 hours of the test result. All participants enrolled by
telephone referral had received a positive chlamydia
test result and the trial manager entered their data on
the day that they were recruited.
We requested all outcome data by post in the ﬁrst
instance and followed up non-responders by email and
phone. At 1 month, we sent an unconditional £5 incen-
tive with the questionnaire. At 3 months, we sent £5
unconditional incentive and a postal chlamydia test kit.
Men were sent a urine test (sensitivity 98.1%, speciﬁcity
99.5%) and women were sent a vulvo-vaginal swab (sen-
sitivity 94.1%, speciﬁcity 99.7%). At 12 months, we sent
an unconditional £10 incentive with the 12-month ques-
tionnaire and test kit. Participants were given the option
of returning their questionnaire by post or completing
the questionnaire on the online database system.
Participants were told that they would receive £20 for
returning the test sample when they received the test
kits. Participants sent the test kit in a prepaid envelope
directly to the laboratory. Recruitment sites provided
clinic data for positive tests during participants’ involve-
ment in the trial (participants consented to this at enrol-
ment). Our approach to developing the follow-up
procedures involved identifying the effective methods to
increase follow-up from systematic reviews, testing proto-
type procedures and consulting with the target group
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regarding the acceptability of the procedures.26 We
assessed the proportion of messages successfully deliv-
ered using our trial database metrics.
Analysis
We conducted all analyses in Stata V.14. We conducted
all analyses once, at the end of the trial. We calculated
the follow-up response as a proportion and report the
95% CI.
See online supplementary ﬁle 3 for the Pilot trial
protocol.
RESULTS
We assessed 470 people for eligibility, of which 169 were
ineligible and 101 declined. Sixty-six per cent of eligible
participants joined the trial (200/301). We randomised
200 participants between 9 September 2013 and 26
November 2013 (ﬁgure 1).23 Ninety-nine participants
were allocated to the intervention and 101 were allo-
cated to the control group. We conducted follow-up
between October 2013 and February 2015. There were
some differences between groups in ethnicity and base-
line infection (table 1). Ninety-two per cent of partici-
pants provided 1-month questionnaire data (183/200),
86% provided a chlamydia test sample at 3 months
(171/200) and 82% provided 12-month questionnaire
data (163/200).26 Fifteen participants requested the
intervention messages to stop (15%, 15/99).
Primary outcomes
We recruited 200 participants within 3 months and we
achieved 81% follow-up completion (162/200, 95% CI
Figure 1 CONSORT diagram.
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74.86 to 86.19) for cumulative incidence of chlamydia at
12 months23 26 (table 2).
Process outcome data
Process outcome data for intervention recipients are
reported in table 3. All intervention messages were sent
successfully from our system. Over 97% of the interven-
tion messages were successfully delivered to participants’
phones, as conﬁrmed by the gateway. At 1 month, 82%
(73/89) of participants in the intervention group
reported reading all messages and at 12 months, 74%
(57/77) reported reading all messages. At 12 months,
two participants in the control group reported reading
messages sent to other trial participants.
Acceptability of the intervention
Participants’ views about the acceptability of the inter-
vention at 1 month are reported in table 4. Over 80% of
intervention recipients reported that the text messages
‘made me think’ (83%, 71/86), were ‘respectful’ (88%,
76/86) and ‘easy to understand’ (95%, 81/85).
Thirty-eight per cent (32/85) of intervention recipients
reported that the messages ‘made me take action’.
About two-thirds of intervention recipients reported that
the messages ‘were from someone they could trust’
(66%, 57/86) and ‘came at the right time of day’ (65%,
56/86). Thirteen per cent (11/85) thought that the
messages talked down to them. Twenty-four per cent
(20/85) thought that there were too many messages and
about 20% (17/85) thought that there were too few.
DISCUSSION
Principal results
The pilot trial demonstrated that the proposed proce-
dures for a fully powered trial were successful. We fully
recruited to target and achieved 81% follow-up for our
proposed primary outcome for the main trial, cumula-
tive incidence of chlamydia at 12 months. Participants’
views suggested that the intervention is acceptable.
Ninety-seven per cent of messages sent were successfully
delivered to participants’ phones.
Strengths and limitations
In the pilot trial, we achieved acceptable follow-up, allo-
cation was concealed and laboratory staff and those ana-
lysing data were blinded to allocation. Only one
researcher who double entered the data was blinded to
allocation. While the trial manager was non-blinded, the
risk of bias associated with this was low as the interven-
tion was delivered by the automated texting software,
not by the trial manager. We present a complete case
analysis of the process outcomes and participants’ views
about the acceptability of the intervention. The main
trial will include sensitivity analyses in relation to missing
data, which could reveal that participants lost to
Table 1 Baseline demographic and sexual behaviour
characteristics
Percentages are of
group total unless
specified
Control
group (%)
Intervention
group (%)
Gender
Male 31/101 (30.69) 29/99 (29.29)
Female 70/101 (69.31) 70/99 (70.71)
Age
Mean (SD) 20.60 (2.39) 20.39 (2.42)
16–19 years 33/101 (32.67) 36/99 (36.36)
20–24 years 68/101 (67.33) 63/99 (63.64)
Ethnicity
White 55/101 (54.46) 59/99 (59.60)
Black 32/101 (31.68) 21/99 (21.21)
Asian 0/101 (0.0) 2/99 (2.0)
Chinese 0/101 (0.0) 0/99 (0.0)
Other 14/101 (13.86) 17/99 (17.17)
Refused/missing 0/101 (0.0) 0/99 (0.0)
Sexual orientation
Heterosexual 83/101 (82.18) 88/99 (88.89)
Gay or lesbian 5/101 (4.95) 3/99 (3.03)
Bisexual 10/101 (9.90) 5/99 (5.05)
Refused/missing 3/101 (2.97) 3/99 (3.03)
STI infection at baseline
No infection 53/101 (52.48) 58/99 (58.59)
Chlamydia-positive 42/101 (41.58) 35/99 (35.35)
Gonorrhoea/NSU 5/101 (4.95) 5/99 (5.05)
Chlamydia/gonorrhoea/
NSU diagnosis
1/101 (0.99) 1/99 (1.01)
Sexual behaviour
Condom use at last sex 35/101 (34.65) 32/99 (32.32)
Condom use at last sex
with someone new
52/101 (51.49) 48/99 (48.48)
Testing prior to last sex
with someone new
37/101 (36.63) 32/99 (32.32)
Partner testing at last
sex with someone new*
12/101 (11.88) 11/99 (11.11)
Number of sexual partners in last 12 months
0 0/101 (0.0) 0/99 (0.0)
1 9/101 (8.91) 6/99 (6.06)
2+ 92/101 (91.09) 93/99 (93.94)
*Participants were asked “The last time you had sex with
someone new, did they get tested for sexually transmitted
infections before you had sex?”.
Table 2 Primary outcome data
Follow-up
Control group
n/N (%)
Intervention group
n/N (%)
Follow-up
n/N (%, 95% CI)
12-month follow-up for cumulative incidence
of chlamydia (trial test kits+clinic data)
82/101 (81.19) 80/99 (80.81) 162/200 (81.0, 74.86 to 86.19)
12-month follow-up for trial test kits 80/101 (79.21) 80/99 (80.81) 160/200 (80.0, 73.78 to 85.31)
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follow-up were less likely to read the messages and less
likely to ﬁnd them acceptable. Given the small sample
and the large number of variables assessed, baseline
characteristics were reasonably well balanced. A larger
sample size in a main trial would allow for better
balance between the arms. The pilot trial was not
powered for behavioural or STI outcomes.
Comparisons with other studies
The pilot trial achieved a higher follow-up response
than a pilot trial of a sexual health website intervention
for young people (‘Sexunzipped’). This trial achieved
45% follow-up using for chlamydia postal test kits and
72% for self-reported data at 3 months.27 Our
approach to developing the follow-up procedures26 was
similar to the approach used in the smoking cessation
txt2stop pilot and main trial, which achieved high
follow-up response.6 28 Additional strategies to increase
follow-up will be developed for the main trial, such as
providing incentives to recruitment sites that have the
highest proportion of participants completing
follow-up.
Effective behavioural support interventions delivered
by mobile phone messaging are inexpensive and can be
delivered with high ﬁdelity at scale.6 29 30 An effective
mobile phone messaging intervention shown to decrease
STI would be inexpensive to deliver at scale with high
ﬁdelity. In contrast, face-to-face STI interventions often
consist of multiple sessions,31–34 which require ongoing
staff training to ensure ﬁdelity in delivery and much
greater resources than safetxt.
Implications for the main trial
We are currently conducting a main trial of the safetxt
intervention, informed by a number of ﬁndings from
the pilot trial to evaluate the effects of the intervention.
The main trial sample size is powered to produce a
precise estimate for the effect of the intervention on
cumulative incidence of STI at 12 months. We will use
the follow-up procedures used in the pilot trial and we
will have enough staff for all those entering data to be
blinded to allocation. In the pilot trial, 75% of partici-
pants that tested positive during the study also tested
positive at enrolment (18/24). In the main trial, only
people that test positive at the time of enrolment are eli-
gible, enabling the trial to achieve the estimated event
rate with a smaller sample size. As the target group in
the main trial differs from the pilot trial, we will monitor
recruitment to enable us to develop strategies to recruit
any groups that are under-represented. In order to
achieve a more demographically diverse sample, we are
also recruiting from clinics with greater numbers of
male clients that report having sex with men. The main
trial will include a mediation analysis of the hypothe-
sised mechanisms of action of the intervention, for
example, we will investigate if the intervention increases
condom use self-efﬁcacy and self-efﬁcacy in telling a
partner about an infection.
The postal test kits and monetary incentives for
returning them were not part of usual care during the
pilot trial, but part of the pilot trial procedures and
delivered to participants in the intervention and the
control group. In the main trial, we are sending postal
test kits at 12 months only, with participants unaware of
the incentive until they receive the kit. It is possible
that offering incentives at 12 months could inﬂuence
self-reported behavioural outcomes, but this would be
equal in both groups. The incentive could not inﬂu-
ence whether or not participants had an STI at 12
months.
Table 3 Process outcome data for intervention recipients
Month 1
n/N (%)
Month 12
n/N (%)
Number of text messages read
All 73/89 (82.02) 57/77 (74.03)
Some 10/89 (11.24) 18/77 (23.38)
None 6/89 (6.74) 2/77 (2.60)
If anyone read messages
sent to the participant
24/92 (26.09) 19/80 (23.75)
If yes, how the participant felt about this
Happy 7/24 (29.17) 8/19 (42.11)
Unhappy 2/24 (8.33) 2/19 (10.53)
OK 15/24 (62.50) 9/19 (47.37)
Table 4 Intervention group participant views regarding the messages at month 1
Agree
n/N (%)
Unsure
n/N (%)
Disagree
n/N (%)
The text messages made me take action 32/85 (37.65) 32/85 (37.65) 21/85 (24.71)
The text messages made me think 71/86 (82.56) 7/86 (8.14) 8/86 (9.30)
The text messages were from someone I could trust 57/86 (66.28) 21/86 (24.42) 8/86 (9.30)
The text messages were respectful 76/86 (88.37) 8/86 (9.30) 2/86 (2.33)
The text messages talked down to me 11/85 (12.94) 15/85 (17.65) 59/85 (69.41)
The text messages were easy to understand 81/85 (95.29) 3/85 (3.53) 1/85 (1.18)
There were too few text messages each day 17/85 (20.0) 18/85 (21.18) 50/85 (58.82)
There were too many text messages each day 20/85 (23.53) 17/85 (20.0) 48/85 (56.47)
I would have liked the text messages to stop sooner 12/86 (13.95) 25/86 (29.07) 49/86 (56.98)
The text messages came at the right time of day 56/86 (65.12) 21/86 (24.42) 9/86 (10.47)
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Modern mobile phones offer an array of options in
which to deliver intervention content. For example,
content can be delivered through app instant messaging,
videos and audio and can involve bidirectional inter-
active content. The main trial will evaluate the content
of the safetxt intervention messages that could be deliv-
ered by alternative modes in the future, such as instant
messaging or private social media messaging, should the
content be shown to be effective.
The sample size of the main trial is 5000 participants.
Of the pilot trial participants with an infection at base-
line, 20% (18/89) had a positive chlamydia test at
12-month follow-up. Based on this and previous studies,3
we estimated the event rate (cumulative incidence of
STI at 12 months) to be 20%. The trial is designed to
detect a reduction in STI from 20% to 16% (RR 0.8).
Taking into account the 2% contamination in the pilot
trial, 5000 participants are required to detect this reduc-
tion with 90% power, allowing for 20% loss to follow-up.
CONCLUSIONS
Our pilot trial has demonstrated that recruitment, ran-
domisation, intervention delivery and follow-up were suc-
cessful. A randomised controlled trial of the safetxt
intervention is feasible and is now ongoing.
Twitter Follow Julia Bailey @juliavbailey
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